The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Physical Activity in Patients With Metastatic Colorectal Cancer Who Receive Palliative First-line Chemotherapy
Official Title: Physical Activity in Patients With Metastatic Colorectal Cancer Who Receive Palliative First-line Chemotherapy. A Multicenter Open Label Randomized Controlled Trial
Study ID: NCT02597075
Brief Summary: The purpose of this study is to assess whether a structured physical activity program (PA) during palliative chemotherapy improves progression-free survival (PFS) and/or patient-reported outcomes (ESAS-r) in patients with metastatic colorectal cancer.
Detailed Description: While safety and feasibility as well as some improvements in fitness, fatigue and certain aspects of quality of life have been shown for physical activity in cancer patients during treatment, none of the pre-requisites above (i-iv) is fulfilled in the setting of patients with advanced colon cancer. However, evidence, primarily from the adjuvant setting, that physical activity impacts on treatment tolerability and tumor progression is a strong enough rationale to now embark on this prospective trial. By assessing in a large randomized controlled trial whether a 12-week structured physical activity program during chemotherapy in patients with newly diagnosed colorectal cancer undergoing standard first-line chemotherapy improves progression-free survival as compared to standard first-line chemotherapy alone, all pre-requisites for a practice-changing intervention are met. The physical exercise ACTIVE-program describes a 12-week exercise program consisting of a combination of a bi-weekly aerobic exercise (cycle ergometer) supervised by a physical therapist and a self-paced increase in physical activity during daily life using a pedometer with a daily step goal as a motivational tool. In addition to the supervised exercise program twice a week, patients of the intervention group are recommended to be physically active at home. All patients will undergo standard systemic therapy for metastatic colorectal cancer. Patients in the care-as-usual group are not actively encouraged to change their physical activity level e.g. to start a fitness program during chemotherapy.
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Universitätsklinikum der PMU Salzburg, Salzburg, , Austria
Klinikum Wels-Grieskirchen GmbH, Wels, , Austria
Tumor Zentrum Aarau, Aarau, , Switzerland
Kantonsspital Aarau, Aarau, , Switzerland
Kantonsspital Baden, Baden, , Switzerland
St. Claraspital, Basel, , Switzerland
Clinical Cancer Research Center at University Hospital Basel, Basel, , Switzerland
Istituto Oncologico della Svizzera Italiana IOSI, Bellinzona, , Switzerland
Spitalzentrum Biel, Biel, , Switzerland
Spitalzentrum Oberwallis, Brig, , Switzerland
Kantonsspital Graubünden, Chur, , Switzerland
Hôpital Fribourgeois HFR, Fribourg, , Switzerland
Hôpitaux Universitaires de Genève, Genève 14, , Switzerland
Centre de Chimiothérapie Anti-Cancéreuse, Lausanne, , Switzerland
Kantonsspital Baselland, Liestal, , Switzerland
Kantonsspital Luzern, Luzern, , Switzerland
Spital Thurgau, Münsterlingen, , Switzerland
Kantonsspital Olten, Olten, , Switzerland
Kantonsspital - St. Gallen, St. Gallen, , Switzerland
SpitalSTS AG Simmental-Thun-Saanenland, Thun, , Switzerland
Onkozentrum - Klinik im Park, Zurich, , Switzerland
UniversitätsSpital Zurich, Zurich, , Switzerland
Onkozentrum Hirslanden Zürich, Zürich, , Switzerland
Stadtspital Triemli, Zürich, , Switzerland
Name: Viviane Hess, Prof Dr med
Affiliation: University Hospital, Basel, Switzerland
Role: STUDY_CHAIR